← Back to headlines
Pfizer’s Lyme Vaccine Misses Mark in Study, Complicating Quest for Approval - WSJ
Pfizer’s Lyme Vaccine Misses Mark in Study, Complicating Quest for Approval WSJ
23 Mar, 18:12 — 23 Mar, 18:12
Sources
Showing 1 of 1 sources
Pfizer’s Lyme Vaccine Misses Mark in Study, Complicating Quest for Approval WSJ
